Two companies are advancing psilocybin research for depression, with promising FDA approvals on the horizon. The future of psychedelic therapy emphasizes trained therapists guiding patients through tailored experiences, utilizing various substances based on individual needs. Clinics will not only treat patients but may also extend support to family members, highlighting a holistic approach to mental health care.
